Across TCGA pan-cancer cohorts, FAM163B mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated FAM163B data layer compared with 22 for mass-spec protein.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher FAM163B mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated FAM163B expression acts as an unfavorable survival marker.

GBM are the cancer types where FAM163B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Median	All	0.187	0.560	.003	10	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: FAM163B tumor-vs-normal RNA expression · all FAM163B data types